Titre:
  • Prevention of pulmonary vascular remodeling and of decreased BMPR-2 expression by losartan therapy in shunt-induced pulmonary hypertension.
Auteur:Rondelet, Benoît; Kerbaul, François; Van Beneden, Ronald; Hubloue, Ives; Huez, Sandrine; Fesler, P.; Remmelink, Myriam; Brimioulle, Serge; Salmon, Isabelle; Naeije, Robert
Informations sur la publication:American journal of physiology. Heart and circulatory physiology, 289, 6, page (H2319-H2324)
Statut de publication:Publié, 2005-12
Sujet CREF:Sciences bio-médicales et agricoles
Mots-clés:Angiopoietin
Angiotensin II
Bone morphogenetic protein receptor-2
Endothelin-1
Left-to-right shunt
MeSH keywords:Animals
Antihypertensive Agents -- administration & dosage
Arteriovenous Shunt, Surgical -- adverse effects
Gene Expression Regulation -- drug effects
Hypertension, Pulmonary -- drug therapy
Hypertension, Pulmonary -- metabolism
Losartan -- administration & dosage
Lung -- blood supply
Lung -- drug effects
Lung -- metabolism
Neovascularization, Pathologic -- etiology
Neovascularization, Pathologic -- metabolism
Neovascularization, Pathologic -- prevention & control
Pulmonary Artery -- drug effects
Pulmonary Artery -- metabolism
Pulmonary Artery -- pathology
Swine
Treatment Outcome
Note générale:Journal Article
Research Support, Non-U.S. Gov't
Langue:Anglais
Identificateurs:urn:issn:0363-6135
info:doi/10.1152/ajpheart.00518.2005
info:pii/00518.2005
info:scp/28144460799
info:pmid/16024566